HS
HighVista Strategies Portfolio holdings
AUM
$272M
This Quarter Return
+1.03%
1 Year Return
+24.34%
3 Year Return
+176.43%
5 Year Return
+271.23%
10 Year Return
+682.63%
AUM
$269M
AUM Growth
+$269M
(-7.3%)
Cap. Flow
-$10.1M
Cap. Flow
% of AUM
-3.75%
Top 10 Holdings %
Top 10 Hldgs %
26.35%
Holding
168
New
26
Increased
41
Reduced
37
Closed
31
Top Buys
| 1 |
Meta Platforms (Facebook)
META
|
$3.1M |
| 2 |
Guardant Health
GH
|
$2.88M |
| 3 |
Janux Therapeutics
JANX
|
$2.48M |
| 4 |
Apellis Pharmaceuticals
APLS
|
$2.32M |
| 5 |
Dynavax Technologies
DVAX
|
$1.73M |
Top Sells
| 1 |
CTLT
CATALENT, INC.
CTLT
|
$4.58M |
| 2 |
Capri Holdings
CPRI
|
$3.3M |
| 3 |
Amgen
AMGN
|
$3.25M |
| 4 |
Maplebear
CART
|
$3.2M |
| 5 |
GE Vernova
GEV
|
$2.6M |
Sector Composition
| 1 | Healthcare | 43.86% |
| 2 | Technology | 16.73% |
| 3 | Consumer Discretionary | 7.18% |
| 4 | Communication Services | 5.42% |
| 5 | Industrials | 4.96% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Invesco DB Commodity Index Tracking Fund
DBC
$1.27B
| $30.7M | 11.42% | 1,436,136 | – | – |
|
2
Amazon
AMZN
$2.44T
| $7.5M | 2.79% | 34,193 +2,000 | +6% | +$439K |
|
|
HCP
3
DELISTED
HashiCorp, Inc. Class A Common Stock
HCP
| $4.45M | 1.66% | 130,200 | – | – |
|
4
Microsoft
MSFT
$3.77T
| $4.45M | 1.66% | 10,558 +3,300 | +45% | +$1.39M |
|
|
ANSS
5
DELISTED
Ansys
ANSS
| $4.32M | 1.61% | 12,800 | – | – |
|
|
JNPR
6
DELISTED
Juniper Networks
JNPR
| $4.3M | 1.6% | 114,700 | – | – |
|
|
HES
7
DELISTED
Hess
HES
| $3.84M | 1.43% | 28,900 | – | – |
|
|
8
Dynavax Technologies
DVAX
$1.19B
| $3.81M | 1.42% | 298,536 +135,828 | +83% | +$1.73M |
|
|
9
Janux Therapeutics
JANX
$1.37B
| $3.73M | 1.39% | 69,715 +46,243 | +197% | +$2.48M |
|
10
Albertsons Companies
ACI
$10.9B
| $3.71M | 1.38% | 188,753 | – | – |
|
11
Vaxcyte
PCVX
$4B
| $3.66M | 1.36% | 44,661 | – | – |
|
|
AMED
12
DELISTED
Amedisys
AMED
| $3.56M | 1.33% | 39,250 | – | – |
|
13
argenx
ARGX
$43.6B
| $3.53M | 1.31% | 5,747 -1,407 | -20% | -$865K |
|
|
14
Apellis Pharmaceuticals
APLS
$3.48B
| $3.47M | 1.29% | 108,714 +72,739 | +202% | +$2.32M |
|
15
XPO
XPO
$15.3B
| $3.38M | 1.26% | 25,780 -11,900 | -32% | -$1.56M |
|
16
Arcellx
ACLX
$3.85B
| $3.36M | 1.25% | 43,804 -11,335 | -21% | -$869K |
|
17
Booking.com
BKNG
$181B
| $3.26M | 1.21% | 657 +300 | +84% | +$1.49M |
|
18
Salesforce
CRM
$245B
| $3.2M | 1.19% | 9,585 -7,000 | -42% | -$2.34M |
|
19
Nuvalent
NUVL
$5.52B
| $3.12M | 1.16% | 39,876 +10,858 | +37% | +$850K |
|
|
20
Meta Platforms (Facebook)
META
$1.86T
| $3.1M | 1.15% | +5,300 | New | +$3.1M |
|
21
Xoma
XOMA
$392M
| $3.01M | 1.12% | 114,548 | – | – |
|
22
Viridian Therapeutics
VRDN
$1.5B
| $2.96M | 1.1% | 154,563 -30,677 | -17% | -$588K |
|
|
23
Guardant Health
GH
$8.41B
| $2.88M | 1.07% | +94,118 | New | +$2.88M |
|
24
GE HealthCare
GEHC
$33.7B
| $2.74M | 1.02% | 35,000 +21,800 | +165% | +$1.7M |
|
25
Xenon Pharmaceuticals
XENE
$2.98B
| $2.62M | 0.97% | 66,788 -6,974 | -9% | -$273K |
|